Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Intangibles (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Intangibles for 8 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Intangibles rose 87.46% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 87.46% year-over-year, with the annual reading at $1.2 million for FY2025, 87.46% up from the prior year.
  • Intangibles for Q4 2025 was $1.2 million at Precision Biosciences, up from $985000.0 in the prior quarter.
  • The five-year high for Intangibles was $2.1 million in Q3 2021, with the low at $375000.0 in Q2 2024.
  • Average Intangibles over 5 years is $1.2 million, with a median of $1.1 million recorded in 2025.
  • The sharpest move saw Intangibles crashed 75.84% in 2024, then surged 153.87% in 2025.
  • Over 5 years, Intangibles stood at $2.0 million in 2021, then crashed by 64.31% to $731000.0 in 2022, then plummeted by 45.28% to $400000.0 in 2023, then skyrocketed by 55.5% to $622000.0 in 2024, then surged by 87.46% to $1.2 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $1.2 million, $985000.0, and $605000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.